Case Summary:

Our client’s petition consisted of four recommendation letters secured by her fellow experts in the field of pharmacoepidemiology to demonstrate that her expertise in the field and her research on utilizing real-world evidence to improve drug safety, accelerate drug development, and reduce healthcare spending has both substantial merit and national importance. One of the recommenders opinionated:

“Over the last decade in the United States, there has been an increasing trend of gabapentinoid use among its citizens. As it has become a more common treatment for spinal cord injuries, diabetic neuropathy, and other chronic pain conditions, there has failed to be a commensurate increase in scientific understanding of the secondary health effects of this drug. [Client] has identified a significant risk of overdose when gabapentinoids are combined with opioids. She has also identified key statistical trends that highlight the need for healthcare providers to closely supervise prescriptions and off-label gabapentinoid intake in patients. Her research is educating healthcare providers on a growing public health threat, providing guidance for improved patient treatment, and supporting positive healthcare outcomes. Her research is, therefore, essential to national public health.”

The other recommenders also highlight her research, which is based on real-world data, is providing strong evidence of the effects of these drugs, improving patient treatment, and substantially enriching the field’s understanding of drug safety. Her scientific efforts, therefore, possess scientific merit of importance.

After thoroughly reviewing our client’s credentials, we were sure that our client must be allowed to continue her work here in the United States without any hurdles. Also, we added the following details in her petition packet to bolster her EB-2 NIW (National Interest Waiver) case.

• Our client, an analyst commodity II armed with a Ph.D. in pharmaceutical science, and a profound understanding of the field unquestionably proves her to be a fit for the national interest waiver visa. We discussed her research on utilizing real-world evidence to evaluate the effectiveness and safety of medications, analyze health care utilization and costs, and investigate treatment patterns in order to improve drug safety, accelerate drug development, and reduce healthcare spending, which is relevant to the public health and health care efficiency.
• We also noted that she has an exceptional record of publication; the 10 peer-reviewed journal articles (6 of them first-authored) she published in no fewer than 2 highly ranked peer-reviewed journals, which has been cited 101 times so far, which confirms that fellow experts from around the world rely on our client’s findings in order to support their own studies. This notable publication and citation record strengthens the fact that her research output benefits the national interest in public health and for this reason, her research must continue to be supported in the United States.
• Moreover, we observed that she has performed review work for several highly acclaimed journals, which speaks to the level of recognition she has attained across the field. Having conducted at least 6 reviews indeed indicates that she is an expert in the field.

By the end, we incorporated the employment letter confirming her current position, and a letter confirming the intent of her employer to hire her in a full-time position along with information regarding her current employer. Therefore, with a triumph rate of 17K+ approved I-140 petitions, the North America Immigration Law Group is comprehended for having remarkable expertise in articulating employment-based visas, thus, this case is counted as one more successful accomplishment for our law firm. We truly thank our client for choosing us for presenting her I-140 NIW case. We wish her well as she pursues her chosen field here in the United States.